A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula (IA), wherein R1, R2, R3 and R4 are as described in the specification.

 
Web www.patentalert.com

< Chemical structure having an affinity for a phospholipid and labeling compound diagnose kit and drug comprising this structure

< Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia

> Acetyl-CoA carboxylase inhibitors

> Deep-vein thrombosis determination apparatus
~ 00231